Real et al. found in estrogen receptor-negative metastatic breast cancer cell lines that activation of the STAT3-Bcl-2 pathway inhibited the autophagy and apoptosis of these cells, increased their survival benefits, and contributed to the development of drug resistance (Real et al., 2018). The gene discussed is STAT3; the disease is breast carcinoma.